img

Global Coagulation Factors Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Coagulation Factors Market Insights, Forecast to 2034

Coagulation factors such as factor V, factor VIII and factor X play a role in blood clotting
Global Coagulation Factors market is expected to reach to US$ 13410 million in 2024, with a positive growth of %, compared with US$ 12770 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Coagulation Factors industry is evaluated to reach US$ 18800 million in 2029. The CAGR will be 5.8% during 2024 to 2029.
The coagulation factors market has experienced substantial growth in recent years. Coagulation factors are essential proteins involved in the blood clotting process, and deficiencies or abnormalities in these factors can lead to bleeding disorders such as hemophilia and von Willebrand disease. The market growth can be attributed to several factors. Firstly, the increasing prevalence of bleeding disorders, driven by factors such as genetic predisposition, aging population, and improved diagnostic capabilities, has fueled the demand for coagulation factor products. Additionally, advancements in recombinant DNA technology and biotechnology have enabled the development of highly purified and more effective coagulation factor concentrates, offering improved treatment options for patients.
Report Covers
This report presents an overview of global Coagulation Factors market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Coagulation Factors market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Takeda
Bayer
CSL
Pfizer
Grifols
Biogen
Octapharma
NovoNordisk
Greencross
Kedrion
BPL
Hualan Bio
RAAS
Segment by Type
Plasma-derived
Recombinant

Segment by Application


Pharmacy
Hospital

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Coagulation Factors plant distribution, commercial date of Coagulation Factors, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Coagulation Factors introduction, etc. Coagulation Factors Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Coagulation Factors
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Coagulation Factors Product Introduction
1.2 Market by Type
1.2.1 Global Coagulation Factors Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Plasma-derived
1.2.3 Recombinant
1.3 Market by Application
1.3.1 Global Coagulation Factors Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Pharmacy
1.3.3 Hospital
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Coagulation Factors Sales Estimates and Forecasts 2018-2029
2.2 Global Coagulation Factors Revenue by Region
2.2.1 Global Coagulation Factors Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Coagulation Factors Revenue by Region (2018-2024)
2.2.3 Global Coagulation Factors Revenue by Region (2024-2029)
2.2.4 Global Coagulation Factors Revenue Market Share by Region (2018-2029)
2.3 Global Coagulation Factors Sales Estimates and Forecasts 2018-2029
2.4 Global Coagulation Factors Sales by Region
2.4.1 Global Coagulation Factors Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Coagulation Factors Sales by Region (2018-2024)
2.4.3 Global Coagulation Factors Sales by Region (2024-2029)
2.4.4 Global Coagulation Factors Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Coagulation Factors Sales by Manufacturers
3.1.1 Global Coagulation Factors Sales by Manufacturers (2018-2024)
3.1.2 Global Coagulation Factors Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Coagulation Factors in 2022
3.2 Global Coagulation Factors Revenue by Manufacturers
3.2.1 Global Coagulation Factors Revenue by Manufacturers (2018-2024)
3.2.2 Global Coagulation Factors Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Coagulation Factors Revenue in 2022
3.3 Global Key Players of Coagulation Factors, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Coagulation Factors Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Coagulation Factors Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Coagulation Factors, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Coagulation Factors, Product Offered and Application
3.8 Global Key Manufacturers of Coagulation Factors, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Coagulation Factors Sales by Type
4.1.1 Global Coagulation Factors Historical Sales by Type (2018-2024)
4.1.2 Global Coagulation Factors Forecasted Sales by Type (2024-2029)
4.1.3 Global Coagulation Factors Sales Market Share by Type (2018-2029)
4.2 Global Coagulation Factors Revenue by Type
4.2.1 Global Coagulation Factors Historical Revenue by Type (2018-2024)
4.2.2 Global Coagulation Factors Forecasted Revenue by Type (2024-2029)
4.2.3 Global Coagulation Factors Revenue Market Share by Type (2018-2029)
4.3 Global Coagulation Factors Price by Type
4.3.1 Global Coagulation Factors Price by Type (2018-2024)
4.3.2 Global Coagulation Factors Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Coagulation Factors Sales by Application
5.1.1 Global Coagulation Factors Historical Sales by Application (2018-2024)
5.1.2 Global Coagulation Factors Forecasted Sales by Application (2024-2029)
5.1.3 Global Coagulation Factors Sales Market Share by Application (2018-2029)
5.2 Global Coagulation Factors Revenue by Application
5.2.1 Global Coagulation Factors Historical Revenue by Application (2018-2024)
5.2.2 Global Coagulation Factors Forecasted Revenue by Application (2024-2029)
5.2.3 Global Coagulation Factors Revenue Market Share by Application (2018-2029)
5.3 Global Coagulation Factors Price by Application
5.3.1 Global Coagulation Factors Price by Application (2018-2024)
5.3.2 Global Coagulation Factors Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Coagulation Factors Market Size by Type
6.1.1 US & Canada Coagulation Factors Sales by Type (2018-2029)
6.1.2 US & Canada Coagulation Factors Revenue by Type (2018-2029)
6.2 US & Canada Coagulation Factors Market Size by Application
6.2.1 US & Canada Coagulation Factors Sales by Application (2018-2029)
6.2.2 US & Canada Coagulation Factors Revenue by Application (2018-2029)
6.3 US & Canada Coagulation Factors Market Size by Country
6.3.1 US & Canada Coagulation Factors Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Coagulation Factors Sales by Country (2018-2029)
6.3.3 US & Canada Coagulation Factors Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Coagulation Factors Market Size by Type
7.1.1 Europe Coagulation Factors Sales by Type (2018-2029)
7.1.2 Europe Coagulation Factors Revenue by Type (2018-2029)
7.2 Europe Coagulation Factors Market Size by Application
7.2.1 Europe Coagulation Factors Sales by Application (2018-2029)
7.2.2 Europe Coagulation Factors Revenue by Application (2018-2029)
7.3 Europe Coagulation Factors Market Size by Country
7.3.1 Europe Coagulation Factors Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Coagulation Factors Sales by Country (2018-2029)
7.3.3 Europe Coagulation Factors Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Coagulation Factors Market Size
8.1.1 China Coagulation Factors Sales (2018-2029)
8.1.2 China Coagulation Factors Revenue (2018-2029)
8.2 China Coagulation Factors Market Size by Application
8.2.1 China Coagulation Factors Sales by Application (2018-2029)
8.2.2 China Coagulation Factors Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Coagulation Factors Market Size by Type
9.1.1 Asia Coagulation Factors Sales by Type (2018-2029)
9.1.2 Asia Coagulation Factors Revenue by Type (2018-2029)
9.2 Asia Coagulation Factors Market Size by Application
9.2.1 Asia Coagulation Factors Sales by Application (2018-2029)
9.2.2 Asia Coagulation Factors Revenue by Application (2018-2029)
9.3 Asia Coagulation Factors Sales by Region
9.3.1 Asia Coagulation Factors Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Coagulation Factors Revenue by Region (2018-2029)
9.3.3 Asia Coagulation Factors Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Coagulation Factors Market Size by Type
10.1.1 Middle East, Africa and Latin America Coagulation Factors Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Coagulation Factors Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Coagulation Factors Market Size by Application
10.2.1 Middle East, Africa and Latin America Coagulation Factors Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Coagulation Factors Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Coagulation Factors Sales by Country
10.3.1 Middle East, Africa and Latin America Coagulation Factors Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Coagulation Factors Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Coagulation Factors Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Takeda
11.1.1 Takeda Company Information
11.1.2 Takeda Overview
11.1.3 Takeda Coagulation Factors Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Takeda Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Takeda Recent Developments
11.2 Bayer
11.2.1 Bayer Company Information
11.2.2 Bayer Overview
11.2.3 Bayer Coagulation Factors Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Bayer Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 CSL
11.3.1 CSL Company Information
11.3.2 CSL Overview
11.3.3 CSL Coagulation Factors Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 CSL Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CSL Recent Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Coagulation Factors Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Pfizer Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Grifols
11.5.1 Grifols Company Information
11.5.2 Grifols Overview
11.5.3 Grifols Coagulation Factors Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Grifols Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Grifols Recent Developments
11.6 Biogen
11.6.1 Biogen Company Information
11.6.2 Biogen Overview
11.6.3 Biogen Coagulation Factors Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Biogen Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Biogen Recent Developments
11.7 Octapharma
11.7.1 Octapharma Company Information
11.7.2 Octapharma Overview
11.7.3 Octapharma Coagulation Factors Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Octapharma Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Octapharma Recent Developments
11.8 NovoNordisk
11.8.1 NovoNordisk Company Information
11.8.2 NovoNordisk Overview
11.8.3 NovoNordisk Coagulation Factors Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 NovoNordisk Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 NovoNordisk Recent Developments
11.9 Greencross
11.9.1 Greencross Company Information
11.9.2 Greencross Overview
11.9.3 Greencross Coagulation Factors Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Greencross Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Greencross Recent Developments
11.10 Kedrion
11.10.1 Kedrion Company Information
11.10.2 Kedrion Overview
11.10.3 Kedrion Coagulation Factors Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Kedrion Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Kedrion Recent Developments
11.11 BPL
11.11.1 BPL Company Information
11.11.2 BPL Overview
11.11.3 BPL Coagulation Factors Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 BPL Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 BPL Recent Developments
11.12 Hualan Bio
11.12.1 Hualan Bio Company Information
11.12.2 Hualan Bio Overview
11.12.3 Hualan Bio Coagulation Factors Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Hualan Bio Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Hualan Bio Recent Developments
11.13 RAAS
11.13.1 RAAS Company Information
11.13.2 RAAS Overview
11.13.3 RAAS Coagulation Factors Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 RAAS Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 RAAS Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Coagulation Factors Industry Chain Analysis
12.2 Coagulation Factors Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Coagulation Factors Production Mode & Process
12.4 Coagulation Factors Sales and Marketing
12.4.1 Coagulation Factors Sales Channels
12.4.2 Coagulation Factors Distributors
12.5 Coagulation Factors Customers
13 Market Dynamics
13.1 Coagulation Factors Industry Trends
13.2 Coagulation Factors Market Drivers
13.3 Coagulation Factors Market Challenges
13.4 Coagulation Factors Market Restraints
14 Key Findings in The Global Coagulation Factors Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Coagulation Factors Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Plasma-derived
Table 3. Major Manufacturers of Recombinant
Table 4. Global Coagulation Factors Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Coagulation Factors Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Coagulation Factors Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Coagulation Factors Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Coagulation Factors Revenue Market Share by Region (2018-2024)
Table 9. Global Coagulation Factors Revenue Market Share by Region (2024-2029)
Table 10. Global Coagulation Factors Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Coagulation Factors Sales by Region (2018-2024) & (K Units)
Table 12. Global Coagulation Factors Sales by Region (2024-2029) & (K Units)
Table 13. Global Coagulation Factors Sales Market Share by Region (2018-2024)
Table 14. Global Coagulation Factors Sales Market Share by Region (2024-2029)
Table 15. Global Coagulation Factors Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Coagulation Factors Sales Share by Manufacturers (2018-2024)
Table 17. Global Coagulation Factors Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Coagulation Factors Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Coagulation Factors, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Coagulation Factors Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Coagulation Factors Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Coagulation Factors by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Coagulation Factors as of 2022)
Table 23. Global Key Manufacturers of Coagulation Factors, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Coagulation Factors, Product Offered and Application
Table 25. Global Key Manufacturers of Coagulation Factors, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Coagulation Factors Sales by Type (2018-2024) & (K Units)
Table 28. Global Coagulation Factors Sales by Type (2024-2029) & (K Units)
Table 29. Global Coagulation Factors Sales Share by Type (2018-2024)
Table 30. Global Coagulation Factors Sales Share by Type (2024-2029)
Table 31. Global Coagulation Factors Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Coagulation Factors Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Coagulation Factors Revenue Share by Type (2018-2024)
Table 34. Global Coagulation Factors Revenue Share by Type (2024-2029)
Table 35. Coagulation Factors Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Coagulation Factors Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Coagulation Factors Sales by Application (2018-2024) & (K Units)
Table 38. Global Coagulation Factors Sales by Application (2024-2029) & (K Units)
Table 39. Global Coagulation Factors Sales Share by Application (2018-2024)
Table 40. Global Coagulation Factors Sales Share by Application (2024-2029)
Table 41. Global Coagulation Factors Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Coagulation Factors Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Coagulation Factors Revenue Share by Application (2018-2024)
Table 44. Global Coagulation Factors Revenue Share by Application (2024-2029)
Table 45. Coagulation Factors Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Coagulation Factors Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Coagulation Factors Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Coagulation Factors Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Coagulation Factors Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Coagulation Factors Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Coagulation Factors Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Coagulation Factors Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Coagulation Factors Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Coagulation Factors Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Coagulation Factors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Coagulation Factors Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Coagulation Factors Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Coagulation Factors Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Coagulation Factors Sales by Country (2024-2029) & (K Units)
Table 60. Europe Coagulation Factors Sales by Type (2018-2024) & (K Units)
Table 61. Europe Coagulation Factors Sales by Type (2024-2029) & (K Units)
Table 62. Europe Coagulation Factors Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Coagulation Factors Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Coagulation Factors Sales by Application (2018-2024) & (K Units)
Table 65. Europe Coagulation Factors Sales by Application (2024-2029) & (K Units)
Table 66. Europe Coagulation Factors Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Coagulation Factors Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Coagulation Factors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Coagulation Factors Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Coagulation Factors Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Coagulation Factors Sales by Country (2018-2024) & (K Units)
Table 72. Europe Coagulation Factors Sales by Country (2024-2029) & (K Units)
Table 73. China Coagulation Factors Sales by Type (2018-2024) & (K Units)
Table 74. China Coagulation Factors Sales by Type (2024-2029) & (K Units)
Table 75. China Coagulation Factors Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Coagulation Factors Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Coagulation Factors Sales by Application (2018-2024) & (K Units)
Table 78. China Coagulation Factors Sales by Application (2024-2029) & (K Units)
Table 79. China Coagulation Factors Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Coagulation Factors Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Coagulation Factors Sales by Type (2018-2024) & (K Units)
Table 82. Asia Coagulation Factors Sales by Type (2024-2029) & (K Units)
Table 83. Asia Coagulation Factors Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Coagulation Factors Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Coagulation Factors Sales by Application (2018-2024) & (K Units)
Table 86. Asia Coagulation Factors Sales by Application (2024-2029) & (K Units)
Table 87. Asia Coagulation Factors Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Coagulation Factors Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Coagulation Factors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Coagulation Factors Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Coagulation Factors Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Coagulation Factors Sales by Region (2018-2024) & (K Units)
Table 93. Asia Coagulation Factors Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Coagulation Factors Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Coagulation Factors Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Coagulation Factors Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Coagulation Factors Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Coagulation Factors Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Coagulation Factors Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Coagulation Factors Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Coagulation Factors Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Coagulation Factors Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Coagulation Factors Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Coagulation Factors Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Coagulation Factors Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Coagulation Factors Sales by Country (2024-2029) & (K Units)
Table 107. Takeda Company Information
Table 108. Takeda Description and Major Businesses
Table 109. Takeda Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Takeda Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Takeda Recent Developments
Table 112. Bayer Company Information
Table 113. Bayer Description and Major Businesses
Table 114. Bayer Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Bayer Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Bayer Recent Developments
Table 117. CSL Company Information
Table 118. CSL Description and Major Businesses
Table 119. CSL Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. CSL Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. CSL Recent Developments
Table 122. Pfizer Company Information
Table 123. Pfizer Description and Major Businesses
Table 124. Pfizer Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Pfizer Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Pfizer Recent Developments
Table 127. Grifols Company Information
Table 128. Grifols Description and Major Businesses
Table 129. Grifols Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Grifols Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Grifols Recent Developments
Table 132. Biogen Company Information
Table 133. Biogen Description and Major Businesses
Table 134. Biogen Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 135. Biogen Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Biogen Recent Developments
Table 137. Octapharma Company Information
Table 138. Octapharma Description and Major Businesses
Table 139. Octapharma Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 140. Octapharma Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Octapharma Recent Developments
Table 142. NovoNordisk Company Information
Table 143. NovoNordisk Description and Major Businesses
Table 144. NovoNordisk Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 145. NovoNordisk Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. NovoNordisk Recent Developments
Table 147. Greencross Company Information
Table 148. Greencross Description and Major Businesses
Table 149. Greencross Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 150. Greencross Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Greencross Recent Developments
Table 152. Kedrion Company Information
Table 153. Kedrion Description and Major Businesses
Table 154. Kedrion Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 155. Kedrion Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Kedrion Recent Developments
Table 157. BPL Company Information
Table 158. BPL Description and Major Businesses
Table 159. BPL Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 160. BPL Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. BPL Recent Developments
Table 162. Hualan Bio Company Information
Table 163. Hualan Bio Description and Major Businesses
Table 164. Hualan Bio Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 165. Hualan Bio Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Hualan Bio Recent Developments
Table 167. RAAS Company Information
Table 168. RAAS Description and Major Businesses
Table 169. RAAS Coagulation Factors Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 170. RAAS Coagulation Factors Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. RAAS Recent Developments
Table 172. Key Raw Materials Lists
Table 173. Raw Materials Key Suppliers Lists
Table 174. Coagulation Factors Distributors List
Table 175. Coagulation Factors Customers List
Table 176. Coagulation Factors Market Trends
Table 177. Coagulation Factors Market Drivers
Table 178. Coagulation Factors Market Challenges
Table 179. Coagulation Factors Market Restraints
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Coagulation Factors Product Picture
Figure 2. Global Coagulation Factors Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Coagulation Factors Market Share by Type in 2022 & 2029
Figure 4. Plasma-derived Product Picture
Figure 5. Recombinant Product Picture
Figure 6. Global Coagulation Factors Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Coagulation Factors Market Share by Application in 2022 & 2029
Figure 8. Pharmacy
Figure 9. Hospital
Figure 10. Coagulation Factors Report Years Considered
Figure 11. Global Coagulation Factors Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Coagulation Factors Revenue 2018-2029 (US$ Million)
Figure 13. Global Coagulation Factors Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Coagulation Factors Revenue Market Share by Region (2018-2029)
Figure 15. Global Coagulation Factors Sales 2018-2029 ((K Units)
Figure 16. Global Coagulation Factors Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Coagulation Factors Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Coagulation Factors Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Coagulation Factors Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Coagulation Factors Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Coagulation Factors Sales YoY (2018-2029) & (K Units)
Figure 22. China Coagulation Factors Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Coagulation Factors Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Coagulation Factors Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Coagulation Factors Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Coagulation Factors Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Coagulation Factors Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Coagulation Factors in the World: Market Share by Coagulation Factors Revenue in 2022
Figure 29. Global Coagulation Factors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Coagulation Factors Sales Market Share by Type (2018-2029)
Figure 31. Global Coagulation Factors Revenue Market Share by Type (2018-2029)
Figure 32. Global Coagulation Factors Sales Market Share by Application (2018-2029)
Figure 33. Global Coagulation Factors Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Coagulation Factors Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Coagulation Factors Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Coagulation Factors Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Coagulation Factors Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Coagulation Factors Revenue Share by Country (2018-2029)
Figure 39. US & Canada Coagulation Factors Sales Share by Country (2018-2029)
Figure 40. U.S. Coagulation Factors Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Coagulation Factors Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Coagulation Factors Sales Market Share by Type (2018-2029)
Figure 43. Europe Coagulation Factors Revenue Market Share by Type (2018-2029)
Figure 44. Europe Coagulation Factors Sales Market Share by Application (2018-2029)
Figure 45. Europe Coagulation Factors Revenue Market Share by Application (2018-2029)
Figure 46. Europe Coagulation Factors Revenue Share by Country (2018-2029)
Figure 47. Europe Coagulation Factors Sales Share by Country (2018-2029)
Figure 48. Germany Coagulation Factors Revenue (2018-2029) & (US$ Million)
Figure 49. France Coagulation Factors Revenue (2018-2029) & (US$ Million)
Figure 50. UK Coagulation Factors Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Coagulation Factors Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Coagulation Factors Revenue (2018-2029) & (US$ Million)
Figure 53. China Coagulation Factors Sales Market Share by Type (2018-2029)
Figure 54. China Coagulation Factors Revenue Market Share by Type (2018-2029)
Figure 55. China Coagulation Factors Sales Market Share by Application (2018-2029)
Figure 56. China Coagulation Factors Revenue Market Share by Application (2018-2029)
Figure 57. Asia Coagulation Factors Sales Market Share by Type (2018-2029)
Figure 58. Asia Coagulation Factors Revenue Market Share by Type (2018-2029)
Figure 59. Asia Coagulation Factors Sales Market Share by Application (2018-2029)
Figure 60. Asia Coagulation Factors Revenue Market Share by Application (2018-2029)
Figure 61. Asia Coagulation Factors Revenue Share by Region (2018-2029)
Figure 62. Asia Coagulation Factors Sales Share by Region (2018-2029)
Figure 63. Japan Coagulation Factors Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Coagulation Factors Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Coagulation Factors Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Coagulation Factors Revenue (2018-2029) & (US$ Million)
Figure 67. India Coagulation Factors Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Coagulation Factors Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Coagulation Factors Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Coagulation Factors Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Coagulation Factors Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Coagulation Factors Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Coagulation Factors Sales Share by Country (2018-2029)
Figure 74. Brazil Coagulation Factors Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Coagulation Factors Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Coagulation Factors Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Coagulation Factors Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Coagulation Factors Revenue (2018-2029) & (US$ Million)
Figure 79. Coagulation Factors Value Chain
Figure 80. Coagulation Factors Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed